Alps Group Inc
For the period ended Aug 7, 2026. Filed Aug 7, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Aug 7, 2026 · Filed Aug 7, 2026
Use the contents to explore the available documents and sections.
ALPS$0.33+4.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Recent Developments
Recent Developments
| ● | Expanded MyGenome Sdn. Bhd.’s laboratory accreditation to include Whole Genome Sequencing (WGS) under MS ISO 15189:2022, positioning MyGenome among a select group of genomics laboratories in Southeast Asia delivering WGS under internationally recognized clinical laboratory standards. |
| ● | Entered into a Research Consultancy and Collaboration Agreement, through subsidiary MyGenome Sdn. Bhd., to establish a clinically validated Patient-Derived Organoid (PDO) platform in Malaysia. |
| ● | Appointed Lee Hee Hang, a former Partner at Ernst & Young LLP, to the Board of Directors, bringing deep audit and financial governance expertise to the Company’s Audit and Compensation Committees. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.